United States: The Long-Awaited 340B Drug Pricing Program Omnibus Guidance: Part II

Last Updated: September 15 2015
Article by Kathleen A. Reed

Covered Entity Eligibility, Registration and Termination

This is the second in a series of updates addressing the 340B Drug Pricing Program Omnibus Guidance published by the Health Resources and Services Administration (HRSA) on August 28, 2015 (Guidance). The proposed Guidance clarifies various aspects of covered entity and drug manufacturer compliance with Section 340B of the Public Health Service Act (PHSA); topics that are currently addressed in a number of HRSA guidance documents published in the Federal Register dating back to 1992. This update addresses issues of covered entity eligibility, registration and termination from the 340B Drug Pricing Program (340B Program).

Together the PHSA and the Affordable Care Act (ACA) enumerate the following types of entities that are eligible to participate in the 340B Program and receive applicable discounts on covered drugs (Covered Entities):

(a) Non-hospital entities that receive certain federal grants, federal contracts, federal designations or establish federally-funded projects (e.g., FQHCs, family planning clinics, black lung clinics, hemophilia clinics, state-operated AIDS drug purchasing programs and STD clinics);

(b) Certain hospital entities that fall into one of the following three categories:

(i) Government owned or operated hospitals;

(ii) Public or private nonprofit hospitals that have been granted government powers (e.g., authority to tax, issue bonds, provide health care on the government's behalf); or

(iii) Private non-profit hospitals that contract with state or local government to provide health care services to low-income individuals who are not eligible for Medicare or Medicaid;

(c) Children's hospitals;

(d) Freestanding cancer hospitals;

(e) Rural referral centers (RRCs); and

(f) Sole community hospitals (SCHs).

Additionally, hospitals in category (b) that are eligible for disproportionate share hospital status, children's hospitals, and freestanding cancer hospitals must also have a Medicaid disproportionate share adjustment greater than 11.75 percent, and RRCs and SCHs must have a disproportionate share adjustment greater than 8 percent in order to participate in the 340B Program. For hospitals that qualify under more than one Covered Entity type, the Department of Health and Human Services (HHS) will list a hospital under only one type at a time on the 340B Program Data Base maintained by HHS. If the hospital loses eligibility under the listed type, it must submit a new registration application for another type during the regular enrollment period.

A health care entity that falls into one or more of the above categories may make application to HRSA for inclusion in its 340B Program Database as a Covered Entity. The proposed Guidance explains the documentation and certification necessary to establish that an applicant falls into the Covered Entity categories listed above. Eligibility for participation in the 340B Program is strictly limited to those types of entities listed in the PHSA and the ACA. The inclusion of an otherwise non-eligible entity in a larger organization that includes one or more eligible Covered Entities (i.e., an accountable care organization) will not cause the otherwise non-eligible entity to become eligible.

The proposed Guidance also explains that a clinic or hospital Covered Entity (referred to as a "parent site") may have one or more off-site clinics or outpatient facilities (referred to as "child sites") that may also be eligible to participate in the 340B Program, provided the various entities satisfy certain requirements outlined in the Guidance.

HRSA accepts applications for enrollment in the 340B Program only during the following four quarterly application periods:

October 1 – October 15

for a January 1 start date

January 1 – January 15

for an April 1 start date

April 1- April 15

for a July 1 start date

July 1 – July 15

for an October 1 start date

The PHSA requires HHS to establish an annual recertification process for all Covered Entities during which Covered Entities must certify the accuracy of their information on the 340B Data Base and their compliance with statutory requirements. According to the Guidance, by making such certification the Covered Entity attests that it uses "effective business practices to ensure and monitor ongoing compliance, including self-audits where appropriate," maintains accurate 340B Data Base information and notifies HHS of loss of eligibility or noncompliance with 340B Program requirements.

The Guidance clarifies that each Covered Entity is obligated to notify HHS in the event that it or a child site is no longer eligible to participate in the 340B Program. When eligibility is lost, HHS will list the Covered Entity's or child site's termination date on the 340B Program Data Base. If a parent site loses eligibility, all associated child sites and contract pharmacies will also be terminated. A child site may, however, lose eligibility without loss of parent site eligibility in certain circumstances.

The Guidance states that a Covered Entity that notifies HHS of loss of eligibility will be expected to give the reason for and the effective date of the loss, and the date the last 340B drug purchases were made. Failure to provide such information will be considered by HHS in any determination regarding the entity's liability to drug manufacturers and in the entity's attempt to re-enroll in the 340B Program. The Guidance makes it clear that a Covered Entity is liable to drug manufacturers for any discount received while it or any child site was ineligible. The Guidance proposes to permit a terminated Covered entity to re-enroll at the next regular enrollment period for which the entity can establish that it is in compliance with all eligibility requirements, and is in the process of offering any applicable repayment to the drug manufacturer.

Dykema will present additional updates on other aspects of the Guidance, including covered drugs, replenishment models, contract pharmacies and the GPO prohibition, and record keeping requirements and audits.

All 340B Covered Entities should evaluate their current practices under the proposed Guidance in preparation for any adjustments that may be required once the Guidance is finalized.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.